May 14, 2021
A key health ministry advisory panel will discuss whether to recommend approval for a batch of new drugs including Chugai Pharmaceutical’s risdiplam, which would be the first oral treatment for spinal muscular atrophy (SMA), at its meeting on May 26...read more